CSTL - Castle Biosciences, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.23
|
Rev Est: $80.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$49.80
DETAILS
HIGH:
$52.00
LOW:
$47.00
MEDIAN:
$50.00
CONSENSUS:
$49.80
UPSIDE:
66.33%
Market Cap:
873.91M
Volume:
526,295
Avg Volume:
393,823
52 Week Range:
14.59-44.28
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
1.05
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
784
IPO Date:
2019-07-25
EPS (TTM):
0.66
P/E Ratio:
40.57
Revenue (TTM):
332.07M
Total Assets:
531.24M
Total Debt:
26.34M
Cash & Equiv:
119.71M
Rev Growth (5Y):
44.9%
EPS Growth (5Y):
13.5%
FCF Growth (5Y):
43.1%
ROCE:
4.6%
Debt/Equity:
0.06
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-03 | $-0.02 | $-0.34 | +94.1% | $83.0M | $80.4M | +3.3% |
| 2025-08-04 | $0.15 | $-0.51 | +129.4% | $86.2M | $68.0M | +26.7% |
| 2025-05-05 | $-0.20 | $-0.08 | -150.0% | $88.0M | $71.8M | +22.5% |
| 2025-02-27 | $0.32 | $-0.04 | +900.0% | $86.3M | $83.9M | +2.9% |
| 2024-11-04 | $0.08 | $-0.06 | +233.3% | $85.8M | $80.6M | +6.5% |
| 2024-08-05 | $0.31 | $-0.27 | +214.8% | $87.0M | $69.3M | +25.5% |
| 2024-05-02 | $-0.09 | $-0.37 | +75.7% | $73.0M | $66.2M | +10.2% |
| 2024-02-28 | $-0.10 | $-0.84 | +88.1% | $66.1M | $56.3M | +17.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 332.07M | 219.79M | 137.04M | 94.08M | 62.65M | 51.87M | 22.79M | 13.75M |
| Net Income | 18.25M | (57.47M) | (67.14M) | (31.29M) | (10.28M) | 5.28M | (6.37M) | (12.37M) |
| EPS | 0.66 | -2.14 | -2.58 | -1.24 | -0.54 | 0.35 | -0.60 | -1.26 |
| Total Assets | 531.24M | 453.34M | 447.33M | 462.57M | 439.33M | 119.75M | 22.40M | 9.82M |
| Total Debt | 26.34M | 15.34M | 13.40M | 8.20M | 0 | 25.12M | 24.50M | 18.60M |
| Cash & Equivalents | 119.71M | 98.84M | 122.95M | 329.63M | 409.85M | 98.84M | 4.48M | 1.21M |
| Operating Cash Flow | 64.87M | (5.63M) | (41.66M) | (18.98M) | 9.87M | 7.01M | (12.29M) | (12.23M) |
| Free Cash Flow | 36.54M | (19.25M) | (47.29M) | (22.47M) | 5.11M | 6.08M | (12.57M) | (12.73M) |
| FCF per Share | 1.32 | -0.72 | -1.81 | -0.89 | 0.27 | 0.71 | -1.18 | -1.30 |
| Book Value | 455.83M | 391.27M | 399.15M | 411.74M | 415.69M | 85.11M | (10.07M) | (14.27M) |
| Cash & ST Investments | 293.13M | 243.10M | 258.62M | 329.63M | 409.85M | 98.84M | 4.48M | 1.21M |
| ROC Equity | 0.04 | -0.15 | -0.17 | -0.08 | -0.02 | 0.06 | N/A | N/A |